CAC Software vs EchoGo Pro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by 4DMedical (Imbio CAC Software)
VS
by Ultromics

AI Verdict

Tool A, Imbio's CAC Software, focuses on quantifying coronary artery calcification from non-contrast chest CT scans to assess CAD risk. Tool B, Ultromics' EchoGo Pro, automates stress echocardiography analysis to improve the diagnosis of coronary artery disease. While both aim to aid in the assessment of coronary artery disease, they utilize distinct imaging modalities and analytical approaches, making them complementary rather than direct substitutes.

Choose CAC Software if…

Choose Imbio's CAC Software if you need to opportunistically assess a patient's risk for coronary artery disease using existing non-contrast chest CT scans. This tool is ideal for quantifying coronary artery calcification, providing an Agatston score and other metrics to aid in early risk stratification without requiring additional dedicated cardiac imaging.

View CAC Software →

Choose EchoGo Pro if…

Choose Ultromics' EchoGo Pro if your primary goal is to enhance the diagnostic accuracy and efficiency of stress echocardiography for coronary artery disease. This AI-powered cloud solution is best suited for automating the analysis of stress echo images, providing near-instant, comprehensive reports to support clinical decision-making in a cardiology setting.

View EchoGo Pro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CAC Software EchoGo Pro
Pricing Unknown Contact vendor for pricing
Deployment Cloud-based (SaaS), integrates with PACS Cloud-based
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoGo Pro

EchoGo Pro emphasizes a cloud-based SaaS model that requires no software installation or extensive training, suggesting a lower barrier to entry and easier adoption. It also highlights seamless integration with existing clinical workflows (DICOM, HL7) and vendor-neutrality. CAC Software also integrates into existing DICOM workflows but doesn't explicitly mention the ease of setup or training in the same way.

Clinical Value

Tie

Both tools offer significant clinical value in diagnosing coronary artery disease (CAD) through AI-powered analysis of medical images. CAC Software provides quantitative outputs like Agatston score and arterial age from CT scans, which are crucial for risk assessment. EchoGo Pro automates stress echocardiography analysis to improve diagnostic accuracy and reduce misdiagnosis, addressing a critical need in a complex procedure. Both contribute substantially to cardiac diagnosis and patient care.

Pricing & Value

EchoGo Pro

While both require contacting the vendor for pricing, EchoGo Pro provides details on available reimbursement codes for related products (e.g., CPT 0932T, NTAP XXE2X19). This transparency around potential reimbursement pathways offers a clearer understanding of the financial value proposition for adopting institutions, which is a significant advantage over CAC Software's 'contact for pricing' only statement.

Enterprise Readiness

CAC Software

Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, indicating strong foundational enterprise readiness. However, CAC Software offers greater deployment flexibility with options for Cloud, On-premise, and Partner platforms. This broader range of deployment choices can be crucial for enterprises with specific IT infrastructure requirements or data governance policies, giving it an edge in adaptability.

Innovation

Tie

Both tools leverage AI and deep learning to automate and enhance cardiac imaging analysis, representing significant innovation in their respective domains. CAC Software innovates by automating the quantification of coronary artery calcification from non-contrast CTs, a key risk marker. EchoGo Pro innovates by automating the complex and often operator-dependent analysis of stress echocardiography to improve diagnostic accuracy. Both apply advanced AI to critical clinical challenges.

Support & Docs

Tie

Neither the provided structured facts nor general web searches reveal a clear differentiator in the quality or extent of support and documentation for either product. Both Imbio and Ultromics, as established healthcare AI companies, appear to offer standard customer support and resources like white papers and case studies. Without more specific comparative information, it is not possible to pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CAC Software EchoGo Pro
Name CAC Software EchoGo Pro
Company Imbio Ultromics
Description Automated image post-processing algorithms designed to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries in patients who have undergone a non-contrast, chest computed tomography (CT). FDA-cleared, AI-powered cloud solution that automates stress echocardiography analysis to improve the diagnosis of coronary artery disease, providing near-instant, accurate reports.
Primary Modality Non-contrast chest CT Echocardiography (stress echocardiography)
Key Output/Function Quantification of calcification within coronary arteries (Agatston score, arterial age, calcified lesion mass and volume), 3D visualizations and annotated images. Automated stress echocardiography analysis, near-instant, comprehensive reports for coronary artery disease diagnosis.

Videos

Demos, reviews, and walkthroughs featuring CAC Software and EchoGo Pro.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio's Coronary Artery Calcification (CAC) software is designed to analyze non-contrast chest computed tomography (CT) scans to evaluate calcification within the coronary arteries. EchoGo Pro by Ultromics, on the other hand, automates the analysis of stress echocardiography to aid in the diagnosis of coronary artery disease.
Imbio's CAC software provides quantitative outputs such as the Agatston score, arterial age, calcified lesion mass, and volume, along with 3D visualizations and annotated images. EchoGo Pro delivers near-instant, comprehensive reports for automated stress echocardiography analysis, aiming to improve diagnostic accuracy for coronary artery disease.
Imbio's CAC software is designed to assist both radiologists and cardiologists in their assessment of coronary artery calcifications. EchoGo Pro is primarily focused on supporting cardiologists in the diagnosis of coronary artery disease through echocardiography.
Imbio's CAC software supports risk assessment for coronary artery disease by quantifying calcification within the coronary arteries from CT scans. EchoGo Pro is an AI-powered decision support system indicated as an adjunct to diagnostic stress echocardiography for patients undergoing assessment for CAD, aiming to improve diagnostic accuracy.
While both tools require contacting the vendor for pricing, Ultromics mentions that reimbursement codes are available for related EchoGo products, such as CPT 0932T for EchoGo Heart Failure in outpatient settings and NTAP XXE2X19 for inpatient settings. Imbio's CAC software does not specify any available reimbursement codes in the provided information.
Both Imbio's CAC software and Ultromics' EchoGo Pro are designed to integrate into existing DICOM viewing workflows. EchoGo Pro also highlights seamless integration with HL7 and its vendor-neutral compatibility with any PACS.
AI Tool Finder
AI-powered search. Results may not be comprehensive.